| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6613725
[patent_doc_number] => 20020015970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-07
[patent_title] => 'Novel methods of diagnosis of angiogenesis, compositions, and methods of screening for angiogenesis modulators'
[patent_app_type] => new
[patent_app_number] => 09/738877
[patent_app_country] => US
[patent_app_date] => 2000-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 27664
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20020015970.pdf
[firstpage_image] =>[orig_patent_app_number] => 09738877
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/738877 | Novel methods of diagnosis of angiogenesis, compositions, and methods of screening for angiogenesis modulators | Dec 14, 2000 | Abandoned |
| 60/367360 | Novel death domain proteins | Nov 16, 2000 | Pending |
Array
(
[id] => 778986
[patent_doc_number] => 06994852
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-02-07
[patent_title] => 'Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5'
[patent_app_type] => utility
[patent_app_number] => 10/129946
[patent_app_country] => US
[patent_app_date] => 2000-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 6654
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/994/06994852.pdf
[firstpage_image] =>[orig_patent_app_number] => 10129946
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/129946 | Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5 | Nov 9, 2000 | Issued |
Array
(
[id] => 1559262
[patent_doc_number] => 06436629
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-20
[patent_title] => 'Modulating angiogenesis'
[patent_app_type] => B1
[patent_app_number] => 09/697854
[patent_app_country] => US
[patent_app_date] => 2000-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6376
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/436/06436629.pdf
[firstpage_image] =>[orig_patent_app_number] => 09697854
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/697854 | Modulating angiogenesis | Oct 26, 2000 | Issued |
Array
(
[id] => 1305726
[patent_doc_number] => 06617102
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-09
[patent_title] => 'Tankyrase H, compositions involved in the cell cycle and methods of use'
[patent_app_type] => B1
[patent_app_number] => 09/696668
[patent_app_country] => US
[patent_app_date] => 2000-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 30540
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/617/06617102.pdf
[firstpage_image] =>[orig_patent_app_number] => 09696668
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/696668 | Tankyrase H, compositions involved in the cell cycle and methods of use | Oct 24, 2000 | Issued |
| 09/691492 | Method for the genetic analysis of proliferating cells | Oct 17, 2000 | Abandoned |
Array
(
[id] => 1344321
[patent_doc_number] => 06579525
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-06-17
[patent_title] => 'Pharmaceutical compositions comprising erythropoietin for treatment of cancer'
[patent_app_type] => B1
[patent_app_number] => 09/647761
[patent_app_country] => US
[patent_app_date] => 2000-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 8583
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/579/06579525.pdf
[firstpage_image] =>[orig_patent_app_number] => 09647761
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/647761 | Pharmaceutical compositions comprising erythropoietin for treatment of cancer | Oct 4, 2000 | Issued |
| 09/684458 | Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization | Oct 4, 2000 | Abandoned |
Array
(
[id] => 1009260
[patent_doc_number] => 06900022
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-05-31
[patent_title] => 'Prostate cancer-specific marker'
[patent_app_type] => utility
[patent_app_number] => 09/680121
[patent_app_country] => US
[patent_app_date] => 2000-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 22018
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/900/06900022.pdf
[firstpage_image] =>[orig_patent_app_number] => 09680121
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/680121 | Prostate cancer-specific marker | Oct 3, 2000 | Issued |
| 09/675904 | Methods for diagnosis and therapy of hematological and virus-associated malignancies | Sep 27, 2000 | Abandoned |
| 09/670128 | Methods for cancer prognosis and screening antiproliferative agents | Sep 25, 2000 | Abandoned |
Array
(
[id] => 1334829
[patent_doc_number] => 06596851
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-22
[patent_title] => 'Inducible phosphofructokinase and the Warburg effect'
[patent_app_type] => B1
[patent_app_number] => 09/670216
[patent_app_country] => US
[patent_app_date] => 2000-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8548
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/596/06596851.pdf
[firstpage_image] =>[orig_patent_app_number] => 09670216
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/670216 | Inducible phosphofructokinase and the Warburg effect | Sep 24, 2000 | Issued |
Array
(
[id] => 642205
[patent_doc_number] => 07122630
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-10-17
[patent_title] => 'SYK-UBP polypeptides and methods of making and isolating same'
[patent_app_type] => utility
[patent_app_number] => 10/088960
[patent_app_country] => US
[patent_app_date] => 2000-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 25159
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/122/07122630.pdf
[firstpage_image] =>[orig_patent_app_number] => 10088960
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/088960 | SYK-UBP polypeptides and methods of making and isolating same | Sep 24, 2000 | Issued |
Array
(
[id] => 1392113
[patent_doc_number] => 06537554
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-25
[patent_title] => 'Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis'
[patent_app_type] => B1
[patent_app_number] => 09/658644
[patent_app_country] => US
[patent_app_date] => 2000-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12608
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/537/06537554.pdf
[firstpage_image] =>[orig_patent_app_number] => 09658644
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/658644 | Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis | Sep 10, 2000 | Issued |
Array
(
[id] => 1324365
[patent_doc_number] => 06599495
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-29
[patent_title] => 'Nucleotide and protein sequence of mammastatin and methods of use'
[patent_app_type] => B1
[patent_app_number] => 09/643476
[patent_app_country] => US
[patent_app_date] => 2000-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 17169
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/599/06599495.pdf
[firstpage_image] =>[orig_patent_app_number] => 09643476
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/643476 | Nucleotide and protein sequence of mammastatin and methods of use | Aug 21, 2000 | Issued |
| 09/638280 | Methods for diagnosis and therapy of hematological and virus-associated malignancies | Aug 13, 2000 | Abandoned |
Array
(
[id] => 1511917
[patent_doc_number] => 06472142
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-29
[patent_title] => 'Methods and means for inducing apoptosis by interfering with Bip-like proteins'
[patent_app_type] => B1
[patent_app_number] => 09/581001
[patent_app_country] => US
[patent_app_date] => 2000-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12120
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/472/06472142.pdf
[firstpage_image] =>[orig_patent_app_number] => 09581001
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/581001 | Methods and means for inducing apoptosis by interfering with Bip-like proteins | Jul 23, 2000 | Issued |
Array
(
[id] => 663642
[patent_doc_number] => 07101975
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-09-05
[patent_title] => 'Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and β1 integrins'
[patent_app_type] => utility
[patent_app_number] => 09/615624
[patent_app_country] => US
[patent_app_date] => 2000-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12952
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/101/07101975.pdf
[firstpage_image] =>[orig_patent_app_number] => 09615624
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/615624 | Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and β1 integrins | Jul 12, 2000 | Issued |
Array
(
[id] => 732174
[patent_doc_number] => 07037667
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-05-02
[patent_title] => 'Tumor antigen useful in diagnosis and therapy of prostate and colon cancer'
[patent_app_type] => utility
[patent_app_number] => 09/615285
[patent_app_country] => US
[patent_app_date] => 2000-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 36
[patent_no_of_words] => 43055
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/037/07037667.pdf
[firstpage_image] =>[orig_patent_app_number] => 09615285
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/615285 | Tumor antigen useful in diagnosis and therapy of prostate and colon cancer | Jul 11, 2000 | Issued |
Array
(
[id] => 1034633
[patent_doc_number] => 06875844
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-04-05
[patent_title] => 'Peptide compounds derived from a shifted ORF of the iCE gene'
[patent_app_type] => utility
[patent_app_number] => 10/019219
[patent_app_country] => US
[patent_app_date] => 2000-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 9923
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/875/06875844.pdf
[firstpage_image] =>[orig_patent_app_number] => 10019219
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/019219 | Peptide compounds derived from a shifted ORF of the iCE gene | Jun 26, 2000 | Issued |